HQH

Weekly Report: what happened at HQH last week (1120-1124)?

DPG: Top 25 Big-Yield CEFs

Duff & phelps utility and infrastructure fund has a 9.2% yield. The fund has been slammed for its utilities sector exposure and recent distribution rightsizing. Duff & phelps is one of the top 25 big-yield cefs in the blue harbinger index.

Weekly Report: what happened at HQH last week (1113-1117)?

HQH: Discount To NAV Offers Attractive Entry Opportunity

Abrdn healthcare investors is a closed-ended fund focused on the global biotech & healthcare sector with a 10% dividend yield. Tekla capital management's funds were acquired by abrdn on october 27th. Hqh is currently trading at a 17.28% discount to nav, indicating a potential 10% upside to historical averages.

HQH: New Name But Same Risky Bets On Biotech

Abrdn healthcare investors fund's heavy exposure to biotechnology has led to sub-par returns due to higher interest rates and poor equity risk appetites. Abrdn has renamed the fund but day-to-day management remains the same. I continue to recommend caution with the hqh fund.

Weekly Report: what happened at HQH last week (1106-1110)?

abrdn Healthcare Investors declares $0.38 dividend

Abrdn healthcare investors declares $0.38/share monthly dividend, in line with previous. Payable jan. 10; for shareholders of record nov. 22; ex-div nov. 21. Abrdn healthcare investors (hqh) is a biopharma company.

abrdn Healthcare Investors Closed End Fund: Initial statement of beneficial ownership of securities